Comparative transcriptomics analysis of multidrug-resistant Acinetobacter baumannii in response to treatment with the terpenic compounds thymol and carvacrol

被引:7
|
作者
Cirino, Isis Caroline da Silva [1 ,2 ]
de Santana, Caroline Ferreira [1 ]
Bezerra, Maria Jose Ribeiro [1 ]
Rocha, Igor Vasconcelos [1 ]
Luz, Ana Carolina de Oliveira [1 ]
Coutinho, Henrique Douglas Melo [3 ]
de Figueiredo, Regina Celia Bressan Queiroz [1 ]
Raposo, Antonio [4 ]
Lho, Linda Heejung [5 ]
Han, Heesup [6 ]
Leal-Balbino, Tereza Cristina [1 ]
机构
[1] Aggeu Magalha Inst, Oswaldo Cruz Fdn, Dept Microbiol, Recife, PE, Brazil
[2] Univ Fed Pernambuco, Dept Genet, BR-50670901 Recife, PE, Brazil
[3] Reg Univ Cariri, Dept Biol Chem, BR-63105000 Crato, CE, Brazil
[4] Univ Lusofona Human & Tecnol, Res Ctr Biosci & Hlth Technol, CBIOS, Campo Grande 376, P-1749024 Lisbon, Portugal
[5] Cheongju Univ, Coll Business Div Tourism & Hotel Management, 298 Daesung ro, Cheongju 28503, Chungcheongbugd, South Korea
[6] Sejong Univ, Coll Hospitality & Tourism Management, 98 Gunja Dong, Seoul 143747, South Korea
关键词
Acinetobacter baumannii; MDR; Thymol; Carvacrol; Transcriptomic analysis; EVOLUTION; PROTEINS;
D O I
10.1016/j.biopha.2023.115189
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Acinetobacter baumannii is a gram-negative opportunistic bacterium that has become a major public health concern and a substantial medical challenge due to its ability to acquire multidrug resistance (MDR), extended drug resistance, or pan-drug resistance. In this study, we evaluated the antibacterial activity of thymol and carvacrol alone or in combination against clinical isolates of MDR A. baumannii. Additionally, we used RNAsequency to perform a comparative transcriptomic analysis of the effects of carvacrol and thymol on the Acb35 strain under different treatment conditions. Our results demonstrated that thymol and carvacrol alone, effectively inhibited the bacterial growth of MDR A. baumannii isolates, with a minimum inhibitory concentration (MIC) lower than 500 & mu;g/mL. Furthermore, the combination of thymol and carvacrol exhibited either synergistic (FICI < 0.5) or additive effects (0.5 < FICI < 4), enhancing their antibacterial activity. Importantly, these compounds were found to be non-cytotoxic to Vero cells and did not cause hemolysis in erythrocytes at concentrations that effectively inhibited bacterial growth. Transcriptomic analysis revealed the down-regulation of mRNA associated with ribosomal subunit assemblies under all experimental conditions tested. However, the up-regulation of specific genes encoding stress response proteins and transcriptional regulators varied depending on the experimental condition, particularly in response to the treatment with carvacrol and thymol in combination. Based on our findings, thymol and carvacrol demonstrate promising potential as chemotherapeutic agents for controlling MDR A. baumannii infections. These compounds exhibit strong antibacterial activity, particularly in combination and lower cytotoxicity towards mammalian cells. The observed effects on gene expression provide insights into the underlying mechanisms of action, highlighting the regulation of stress response pathways.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Comparative transcriptomics of multidrug-resistant Acinetobacter baumannii in response to antibiotic treatments
    Hao Qin
    Norman Wai-Sing Lo
    Jacky Loo
    Xiao Lin
    Aldrin Kay-Yuen Yim
    Stephen Kwok-Wing Tsui
    Terrence Chi-Kong Lau
    Margaret Ip
    Ting-Fung Chan
    Scientific Reports, 8
  • [2] Comparative transcriptomics of multidrug-resistant Acinetobacter baumannii in response to antibiotic treatments
    Qin, Hao
    Lo, Norman Wai-Sing
    Loo, Jacky Fong-Chuen
    Lin, Xiao
    Yim, Aldrin Kay-Yuen
    Tsui, Stephen Kwok-Wing
    Lau, Terrence Chi-Kong
    Ip, Margaret
    Chan, Ting-Fung
    SCIENTIFIC REPORTS, 2018, 8
  • [3] Comparative Transcriptomics Analyses Of The Different Growth States Of Multidrug-Resistant Acinetobacter Baumannii
    Li, S.
    Yan, X.
    Li, H.
    Qi, T.
    Wang, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [4] Comparative transcriptomics analyses of the different growth states of multidrug-resistant Acinetobacter baumannii
    Li, Shuai
    Li, Haitao
    Qi, Tianjie
    Yan, Xixin
    Wang, Boli
    Guan, Jitao
    Li, Yu
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 85 : 564 - 574
  • [5] Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii
    Adams, Mark D.
    Goglin, Karrie
    Molyneaux, Neil
    Hujer, Kristine M.
    Lavender, Heather
    Jamison, Jennifer J.
    MacDonald, Ian J.
    Martin, Kristienna M.
    Russo, Thomas
    Campagnari, Anthony A.
    Hujer, Andrea M.
    Bonomo, Robert A.
    Gill, Steven R.
    JOURNAL OF BACTERIOLOGY, 2008, 190 (24) : 8053 - 8064
  • [6] Epidemiology and Treatment of Multidrug-Resistant Acinetobacter baumannii
    Rocío Álvarez-Marín
    José Molina Gil-Bermejo
    José M. Cisneros
    Current Treatment Options in Infectious Diseases, 2014, 6 (4) : 409 - 424
  • [7] Multidrug-resistant Acinetobacter baumannii
    Abbo, A
    Navon-Venezia, S
    Orly, HM
    Krichali, T
    Siegman-Igra, Y
    Carmeli, Y
    EMERGING INFECTIOUS DISEASES, 2005, 11 (01) : 22 - 29
  • [8] Multidrug-resistant Acinetobacter baumannii
    Krcmery, Vladimir
    Kalavsky, Erich
    EMERGING INFECTIOUS DISEASES, 2007, 13 (06) : 943 - 944
  • [9] Optimal Therapy for Multidrug-Resistant Acinetobacter baumannii Response
    Paterson, David L.
    Doi, Yohei
    EMERGING INFECTIOUS DISEASES, 2010, 16 (01) : 171 - 171
  • [10] Drug treatment for multidrug-resistant Acinetobacter baumannii infections
    Bassetti, Matteo
    Righi, Elda
    Esposito, Silvano
    Petrosillo, Nicola
    Nicolini, Laura
    FUTURE MICROBIOLOGY, 2008, 3 (06) : 649 - 660